These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11489591)

  • 1. Fetal effects of cocaine: an updated meta-analysis.
    Addis A; Moretti ME; Ahmed Syed F; Einarson TR; Koren G
    Reprod Toxicol; 2001; 15(4):341-69. PubMed ID: 11489591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental abruption and premature rupture of membranes.
    Markhus VH; Rasmussen S; Lie SA; Irgens LM
    Acta Obstet Gynecol Scand; 2011 Sep; 90(9):1024-9. PubMed ID: 21692757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal effects of amphetamine and heroin use during pregnancy on the mother and infant.
    Thaithumyanon P; Limpongsanurak S; Praisuwanna P; Punnahitanon S
    J Med Assoc Thai; 2005 Nov; 88(11):1506-13. PubMed ID: 16471094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis.
    Lutiger B; Graham K; Einarson TR; Koren G
    Teratology; 1991 Oct; 44(4):405-14. PubMed ID: 1835806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental abruption and its association with hypertension and prolonged rupture of membranes: a methodologic review and meta-analysis.
    Ananth CV; Savitz DA; Williams MA
    Obstet Gynecol; 1996 Aug; 88(2):309-18. PubMed ID: 8692522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crack abuse during pregnancy: maternal, fetal and neonatal complication.
    Aghamohammadi A; Zafari M
    J Matern Fetal Neonatal Med; 2016 Mar; 29(5):795-7. PubMed ID: 25747949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: I. Interactive and dose effects on health and growth.
    Eyler FD; Behnke M; Conlon M; Woods NS; Wobie K
    Pediatrics; 1998 Feb; 101(2):229-37. PubMed ID: 9445496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine use in pregnancy.
    Chasnoff IJ; Burns WJ; Schnoll SH; Burns KA
    N Engl J Med; 1985 Sep; 313(11):666-9. PubMed ID: 4022059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal cocaine exposure and fetal vascular disruption.
    Hoyme HE; Jones KL; Dixon SD; Jewett T; Hanson JW; Robinson LK; Msall ME; Allanson JE
    Pediatrics; 1990 May; 85(5):743-7. PubMed ID: 2330234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks associated with cocaine use during pregnancy.
    Slutsker L
    Obstet Gynecol; 1992 May; 79(5 ( Pt 1)):778-89. PubMed ID: 1565365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of spontaneous premature rupture of membranes: factors in pre-term births.
    Miller HC; Jekel JF
    Yale J Biol Med; 1989; 62(3):241-51. PubMed ID: 2815840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripartum cocaine use: estimating risk of adverse pregnancy outcome.
    Cohen HR; Green JR; Crombleholme WR
    Int J Gynaecol Obstet; 1991 May; 35(1):51-4. PubMed ID: 1680076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response effect of fetal cocaine exposure on newborn neurologic function.
    Chiriboga CA; Brust JC; Bateman D; Hauser WA
    Pediatrics; 1999 Jan; 103(1):79-85. PubMed ID: 9917443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of primary symptoms in women with placental abruption.
    Mei Y; Lin Y
    J Matern Fetal Neonatal Med; 2018 Sep; 31(18):2446-2449. PubMed ID: 28629246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of the subtypes of preterm birth with retinopathy of prematurity.
    Lynch AM; Wagner BD; Hodges JK; Thevarajah TS; McCourt EA; Cerda AM; Mandava N; Gibbs RS; Palestine AG
    Am J Obstet Gynecol; 2017 Sep; 217(3):354.e1-354.e8. PubMed ID: 28545834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking and respiratory conditions in pregnancy: associations with adverse pregnancy outcomes.
    Kitsantas P; Christopher KE
    South Med J; 2013 May; 106(5):310-5. PubMed ID: 23644639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal, fetal and neonatal consequences associated with the use of crack cocaine during the gestational period: a systematic review and meta-analysis.
    Dos Santos JF; de Melo Bastos Cavalcante C; Barbosa FT; Gitaí DLG; Duzzioni M; Tilelli CQ; Shetty AK; de Castro OW
    Arch Gynecol Obstet; 2018 Sep; 298(3):487-503. PubMed ID: 29951712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The search for congenital malformations in newborns with fetal cocaine exposure.
    Behnke M; Eyler FD; Garvan CW; Wobie K
    Pediatrics; 2001 May; 107(5):E74. PubMed ID: 11331724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental abruption associated with cocaine use: case report.
    Landy HJ; Hinson J
    Reprod Toxicol; 1987-1988; 1(3):203-5. PubMed ID: 2980384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ondansetron in pregnancy and risk of adverse fetal outcomes.
    Pasternak B; Svanström H; Hviid A
    N Engl J Med; 2013 Feb; 368(9):814-23. PubMed ID: 23445092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.